Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;57(7):1144-1153.
doi: 10.1080/10826084.2022.2064509. Epub 2022 Apr 21.

Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities

Suzan M Walters  1   2 , David C Perlman  2   3 , Honoria Guarino  2   4 , Pedro Mateu-Gelabert  2   4 , David Frank  1   2
Affiliations

Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities

Suzan M Walters et al. Subst Use Misuse. 2022.

Abstract

Background Medications for Opioid Use Disorder (MOUD) are associated with important public health benefits. Program changes implemented in response to COVID-19 hold promise as ongoing strategies to improve MOUD treatment. Methods: MOUD patients on buprenorphine or methadone, providers, government regulators, and persons who use drugs not in MOUD were recruited in the Northeast region of the United States between June and October of 2020 via advertisements, fliers, and word of mouth. Semi-structured qualitative interviews were conducted. Interviews were professionally transcribed and thematically coded by two independent coders. Results: We conducted interviews with 13 people currently on buprenorphine, 11 currently on methadone, 3 previously on buprenorphine, 4 previously on methadone, and 6 who used drugs but had never been on MOUD. In addition, we interviewed MOUD providers, clinic staff, and government officials at agencies that regulate MOUD. Most participants found increased take-home doses, home medication delivery, and telehealth implemented during COVID-19 to be favorable, reporting that these program changes reduced travel time to clinics, facilitated retention in care, and reduced stigma associated with clinic attendance. However, some participants reported negative consequences of COVID-19, most notably, decreased access to basic resources, such as food, clothing, and harm reduction materials that had previously been distributed at some MOUD clinics. Conclusion: Access to and retention in MOUD can be lifesaving for persons using drugs. COVID-19-impelled program changes, including increased take-home doses, home medication delivery, and telehealth generally improved participants' experiences with MOUD. Making these permanent could improve retention in care.

Keywords: COVID-19; MOUD; medication deliveries; telehealth.

PubMed Disclaimer

References

    1. Abadie R, Gelpi-Acosta C, Aquino-Ruiz F, & Aponte-Melendez Y. (2020). “COVID-19 risks among people who inject drugs in Puerto Rico”. International Journal of Drug Policy, 102903. 10.1016/j.drugpo.2020.102903 - DOI - PMC - PubMed
    1. Altman D. (2013). Power & Community. Routledge.
    1. Amram O, Amiri S, Panwala V, Lutz R, Joudrey PJ, & Socias E. (2021). The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era. The American Journal of Drug and Alcohol Abuse, 47(6), 722–729. 10.1080/00952990.2021.1979991 - DOI - PubMed
    1. Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, Astemborski J, Iversen J, Lim AG, Macgregor L, Morris M, Ong JJ, Platt L, Sack-Davis R, Van Santen DK, Solomon SS, Sypsa V, Valencia J, Van Den Boom W, . . . Strathdee, S. A. (2021). Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. The Lancet Public Health. 10.1016/s2468-2667(21)00013-x - DOI - PMC - PubMed
    1. Aspers P, & Corte U. (2019). What is Qualitative in Qualitative Research. Qualitative Sociology, 42(2), 139–160. 10.1007/s11133-019-9413-7 - DOI - PMC - PubMed

Publication types

MeSH terms